<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We have previously reported that Ginkgolids which contain Ginkgolids A and B (Ginkgolids (A+B), GKAB) reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size in a rat model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>NF-kappaB-inducing kinase (NIK)-IkappaBalpha kinase (IKK) pathway plays an important role in activation of nuclear factor kappaB (NF-kappaB) </plain></SENT>
<SENT sid="2" pm="."><plain>A previous study demonstrated that Ginkgolid B inhibited <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS)- and platelet activating factor (PAF)-induced NF-kappaB activation in rat pleural polymorphonuclear granulocytes </plain></SENT>
<SENT sid="3" pm="."><plain>However, little is known about the inhibitory mechanisms of Ginkgolids on the activation of NF-kappaB </plain></SENT>
<SENT sid="4" pm="."><plain>The present study evaluated the effects of GKAB on NIK/IKK/IkappaB/NF-kappaB signaling pathway in a rat model of permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Rats were subjected to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) by intraluminal suture blockade </plain></SENT>
<SENT sid="6" pm="."><plain>GKAB was injected intravenously (iv) immediately after ischemic <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Western blot analysis was employed to determine alterations in IkappaBalpha, phosphorylated NIK (p-NIK) and phosphorylated IKKalpha (p-IKKalpha) </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemistry was used to confirm the nuclear translocation of NF-kappaB p65 </plain></SENT>
<SENT sid="9" pm="."><plain>RT-PCR was used to detect induction of NF-kappaB target gene c-Myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: The results showed a brief increase in p-NIK levels after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>GKAB blocked <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increases in p-NIK and p-IKKalpha levels, and reversed the decline in IkappaBalpha levels </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-induced nuclear translocation of NF-kappaB p65 was attenuated by GKAB(.) GKAB also repressed the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in expression of NF-kappaB target gene c-Myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: These findings suggest that GKAB-mediated neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> appears to be associated with blocking NF-kappaB activation by suppressing the NIK-IKK pathway </plain></SENT>
</text></document>